Statins, metformin, and RAS inhibitors did not reduce variceal bleeding risk and mortality in a large, real-life cohort of patients with cirrhosis
Fig 3
Kaplan-Meier curves showing transplant-free survival for all patients with comedication (statin, metformin or RASi) or non-comedication (A-C). Bar chart of mortality rates in year 2 with comedication or non-comedication for primary prophylaxis and secondary prophylaxis (D,E). n (total numbers), 1Y (Year 1), 2Y (Year 2), 3Y (Year 3), HR (Hazard-Ratio); 95% CI (95% confidence interval); n.s. (not significant); statistical comparisons were performed by log-rank tests.